• Citer

Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.

par Bezjak, Andrea;Tu, Dongsheng;Bacon, M;Osoba, D;Zee, B;Stuart, G;Roy, J A;Piccart-Gebhart, Martine ;Eisenhauer, Elizabeth
Référence Journal of clinical oncology, 22, 22, page (4595-4603)
Publication Publié, 2004-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
Auteur:	Bezjak, Andrea; Tu, Dongsheng; Bacon, M; Osoba, D; Zee, B; Stuart, G; Roy, J A; Piccart-Gebhart, Martine; Eisenhauer, Elizabeth
Informations sur la publication:	Journal of clinical oncology, 22, 22, page (4595-4603)
Statut de publication:	Publié, 2004-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Abdominal Pain
	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Appetite
	Carcinoma -- drug therapy
	Carcinoma -- pathology
	Carcinoma -- psychology
	Cisplatin -- administration & dosage
	Cyclophosphamide -- administration & dosage
	Emotions
	Female
	Health Status
	Humans
	Middle Aged
	Ovarian Neoplasms -- drug therapy
	Ovarian Neoplasms -- pathology
	Ovarian Neoplasms -- psychology
	Paclitaxel -- administration & dosage
	Quality of Life
	Sleep
	Social Support
	Survival Analysis
Note générale:	Clinical Trial
	Clinical Trial, Phase III
	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2004.08.080
	info:pii/JCO.2004.08.080
	info:scp/16544365861
	info:pmid/15466785